Bladder Cancer – Epidemiology – Extrapolated Worldwide Coverage
DRG’s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key bladder cancer patient populations covering 171 countries and more than 99% of the global population, delivered in an interactive dashboard-style download. Use the extended worldwide coverage data set to:
View 10-year forecasts of the diagnosed unresectable locally advanced or metastatic first-line drug-treatable population and diagnosed incident cases for all 171 countries, stratified by region and World Bank income status.
Aggregate country-level estimates into region-level estimates, according to user preference or as required by regulators for orphan drug designations.
Visualize global correlations between disease risk or patient population size and key indicators of market opportunity such as GDP per capita and healthcare spend per capita.
Generate and export global heat maps of disease risk or patient population size.
The extended worldwide coverage dashboard is available as an Excel file in the “Downloads” section. It is available only to clients with subscriptions to all 45 countries covered by DRG Epidemiology. For subscription and entitlement queries, please contact DRG.email@example.com.
Bladder Cancer - Epidemiology - Extrapolated Worldwide Coverage
Extrapolated Worldwide Coverage
The Global Extrapolator Model
The Global Extrapolation Algorithm
Narendra Parihar, B.D.S., M.P.H., Senior Manager, Epidemiology. Dr Parihar is a team lead at Clarivate Epidemiology. He specializes in modelling and forecasting epidemiology patient populations across multiple indications. His primary areas of interest are cancer epidemiology, rare disease epidemiology, and targeted therapies in cancer. His qualifications include a master’s degree in public health with specialization in health policy, economics, and finance from Tata Institute of Social Sciences Mumbai, and a bachelor’s degree in dental surgery from the Rajasthan University of Health Sciences.